Christopher Martin's involvement with stock holdings shows interesting dynamics over the years. In 2019, he had a significant holding that generated over $900,000 from vested stock, showcasing his deep connection to the company's success. As of 2022, his balance in...

$0.000%

No data yet.

No data yet.

Recent Insider Trades

No insider trades found for this CEO.

Christopher Martin

Ex-CEO of ADC Therapeutics

CM

View Compensation History

2022 Total Compensation

$1.00M

Salary

$450.00K

Bonus

$0.00

Stock

$413.76K

Other

$139.24K